首页> 美国卫生研究院文献>BMC Pharmacology Toxicology >Day-to-day variations during clinical drug monitoring of morphine morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study
【2h】

Day-to-day variations during clinical drug monitoring of morphine morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study

机译:癌症患者中吗啡吗啡-3-葡糖醛酸和吗啡-6-葡糖醛酸血清浓度的临床药物监测期间的每日变化。前瞻性观察研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe feasibility of drug monitoring of serum concentrations of morphine, morphine-6-glucuronide (M6G) and morphine-3-glucuronide (M3G) during chronic morphine therapy is not established. One important factor relevant to drug monitoring is to what extent morphine, M6G and M3G serum concentrations fluctuate during stable morphine treatment.
机译:背景技术在吗啡,吗啡-6-葡萄糖醛酸(M6G)和吗啡-3-葡萄糖醛酸(M3G)慢性吗啡治疗期间监测药物浓度的可行性尚未建立。与药物监测有关的一个重要因素是稳定吗啡治疗期间吗啡,M6G和M3G血清浓度的波动程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号